1. Home
  2. LVRO vs DSGN Comparison

LVRO vs DSGN Comparison

Compare LVRO & DSGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LVRO
  • DSGN
  • Stock Information
  • Founded
  • LVRO 2017
  • DSGN 2017
  • Country
  • LVRO Brazil
  • DSGN United States
  • Employees
  • LVRO N/A
  • DSGN N/A
  • Industry
  • LVRO Blank Checks
  • DSGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • LVRO Finance
  • DSGN Health Care
  • Exchange
  • LVRO Nasdaq
  • DSGN Nasdaq
  • Market Cap
  • LVRO 279.6M
  • DSGN 224.8M
  • IPO Year
  • LVRO N/A
  • DSGN 2021
  • Fundamental
  • Price
  • LVRO $2.15
  • DSGN $3.71
  • Analyst Decision
  • LVRO Hold
  • DSGN Hold
  • Analyst Count
  • LVRO 3
  • DSGN 1
  • Target Price
  • LVRO $3.50
  • DSGN $4.00
  • AVG Volume (30 Days)
  • LVRO 4.6K
  • DSGN 93.8K
  • Earning Date
  • LVRO 07-01-2025
  • DSGN 08-04-2025
  • Dividend Yield
  • LVRO N/A
  • DSGN N/A
  • EPS Growth
  • LVRO N/A
  • DSGN N/A
  • EPS
  • LVRO N/A
  • DSGN N/A
  • Revenue
  • LVRO $1,667,345,189.00
  • DSGN N/A
  • Revenue This Year
  • LVRO N/A
  • DSGN N/A
  • Revenue Next Year
  • LVRO $12.46
  • DSGN N/A
  • P/E Ratio
  • LVRO N/A
  • DSGN N/A
  • Revenue Growth
  • LVRO N/A
  • DSGN N/A
  • 52 Week Low
  • LVRO $2.04
  • DSGN $2.60
  • 52 Week High
  • LVRO $5.80
  • DSGN $7.77
  • Technical
  • Relative Strength Index (RSI)
  • LVRO 40.79
  • DSGN 47.78
  • Support Level
  • LVRO $2.23
  • DSGN $3.66
  • Resistance Level
  • LVRO $2.57
  • DSGN $3.84
  • Average True Range (ATR)
  • LVRO 0.18
  • DSGN 0.25
  • MACD
  • LVRO -0.01
  • DSGN -0.02
  • Stochastic Oscillator
  • LVRO 13.22
  • DSGN 18.06

About LVRO Lavoro Limited

Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.

About DSGN Design Therapeutics Inc.

Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.

Share on Social Networks: